|
US8481043B2
(en)
*
|
2001-06-22 |
2013-07-09 |
Cpex Pharmaceuticals, Inc. |
Nasal immunization
|
|
US20100266638A1
(en)
|
2004-02-26 |
2010-10-21 |
Allergan, Inc. |
Headache treatment method
|
|
US9078892B2
(en)
*
|
2004-02-26 |
2015-07-14 |
Allergan, Inc. |
Methods for treating pain and for treating a medication overuse disorder
|
|
US20050191321A1
(en)
|
2004-02-26 |
2005-09-01 |
Allergan, Inc. |
Methods for treating headache
|
|
JP5276982B2
(ja)
|
2005-08-26 |
2013-08-28 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
オキシトシンの投与による頭痛の処置のための方法
|
|
IL296832A
(en)
*
|
2005-10-18 |
2022-11-01 |
Nat Jewish Health |
Process of preparing red blood cells using conditionally immortalized long-term hematopoietic stem cells and erythropoietin
|
|
EP3069731A1
(en)
|
2005-11-14 |
2016-09-21 |
Labrys Biologics Inc. |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
|
US20080261893A1
(en)
*
|
2006-02-24 |
2008-10-23 |
Denise Barbut |
Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
|
|
WO2007120485A2
(en)
*
|
2006-03-30 |
2007-10-25 |
Cinergen, Llc |
Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
|
|
GB2438834A
(en)
|
2006-06-08 |
2007-12-12 |
Optinose As |
Intranasal protein administration
|
|
US7645767B2
(en)
*
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
|
WO2008112807A1
(en)
*
|
2007-03-12 |
2008-09-18 |
Sarentis Therapeutics, Inc. |
Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
|
|
EP2583551A1
(en)
*
|
2007-03-13 |
2013-04-24 |
National Jewish Health |
Methods for generation of antibodies
|
|
EP2152240A4
(en)
|
2007-06-08 |
2012-05-09 |
Healthpartners Res Foundation |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR REINFORCED TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM
|
|
US9707274B2
(en)
|
2007-06-08 |
2017-07-18 |
Healthpartners Research & Education |
Methods for preventing and treating post-traumatic stress disorder (PTSD)
|
|
WO2009012376A1
(en)
*
|
2007-07-17 |
2009-01-22 |
The Ohio State University Research Foundation |
Compositions and methods for skin care
|
|
WO2009033690A1
(en)
*
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Bfgf (119-126) for therapeutic applications
|
|
KR20100061481A
(ko)
*
|
2007-09-11 |
2010-06-07 |
몬도바이오테크 래보래토리즈 아게 |
치료제로서의 미니가스트린
|
|
WO2009033730A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratoires Ag |
Peptide gxgrgdspca as a therapeutic agent
|
|
KR20100056508A
(ko)
*
|
2007-09-11 |
2010-05-27 |
몬도바이오테크 래보래토리즈 아게 |
폐렴 연쇄상 구균 감염의 치료를 위한 ｂｆｇｆ １－２４ 및 임의의 （ａｒｇ ８）바소프레신의 용도
|
|
WO2009033489A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Glostrup Hospital |
Selective pacl inhibitors for use in the treatment of migraine and headaches
|
|
RU2522493C2
(ru)
|
2008-03-04 |
2014-07-20 |
Пфайзер Лимитед |
Способы лечения хронической боли
|
|
WO2009145956A2
(en)
*
|
2008-03-06 |
2009-12-03 |
The Trustees Of Columbia University In The City Of New York |
Uses of calpain inhibitors to inhibit inflammation
|
|
US20090246273A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Al-Ghananeem Abeer M |
Ketorolac Sublingual Spray for the Treatment of Pain
|
|
SG10201803982TA
(en)
|
2008-05-16 |
2018-07-30 |
Taiga Biotechnologies Inc |
Antibodies and processes for preparing the same
|
|
FR2932483A1
(fr)
*
|
2008-06-13 |
2009-12-18 |
Cytomics Systems |
Composes utiles pour le traitement des cancers.
|
|
SG193145A1
(en)
*
|
2008-07-21 |
2013-09-30 |
Taiga Biotechnologies Inc |
Differentiated anucleated cells and method for preparing the same
|
|
DK3339321T3
(da)
|
2008-08-28 |
2021-06-21 |
Taiga Biotechnologies Inc |
Modulatorer af myc, fremgangsmåder til anvendelse af samme og fremgangsmåder til at identificere stoffer der modulerer myc
|
|
WO2010029555A1
(en)
*
|
2008-09-12 |
2010-03-18 |
Slender Medical, Ltd. |
Virtual ultrasonic scissors
|
|
US20110318345A1
(en)
*
|
2008-09-15 |
2011-12-29 |
Optinose As |
Nasal delivery
|
|
WO2010045599A1
(en)
*
|
2008-10-17 |
2010-04-22 |
Pharmacofore, Inc. |
Pharmaceutical compositions with attenuated release of phenolic opioids
|
|
EP2373680A4
(en)
|
2008-12-08 |
2017-05-24 |
Biousian Biosystems, Inc |
Delta-opioid receptor selective analgesics
|
|
EP2393488B1
(en)
*
|
2009-02-06 |
2019-06-19 |
University Of Southern California |
Therapeutic compositions comprising monoterpenes
|
|
US20100291160A1
(en)
*
|
2009-05-13 |
2010-11-18 |
Carver David R |
Pharmaceutical system for trans-membrane delivery
|
|
JP5669145B2
(ja)
*
|
2009-07-02 |
2015-02-12 |
国立大学法人山口大学 |
表面麻酔剤
|
|
KR20180052610A
(ko)
|
2009-07-27 |
2018-05-18 |
노시셉터 엘엘씨 |
통증 치료 방법
|
|
FR2948809B1
(fr)
*
|
2009-07-31 |
2012-08-17 |
St Microelectronics Rousset |
Amplificateur de lecture faible puissance auto-minute
|
|
CN102740884A
(zh)
|
2009-08-28 |
2012-10-17 |
瑞纳神经科学公司 |
通过施用针对降钙素基因相关肽的拮抗性抗体来治疗内脏痛的方法
|
|
CN102695545B
(zh)
|
2009-09-08 |
2016-08-17 |
特色疗法股份有限公司 |
包括酶可剪切的酮改性的阿片样物质药物前体以及其可任选的抑制剂的组合物
|
|
US8622993B2
(en)
*
|
2009-12-18 |
2014-01-07 |
Healthpartners Research Foundation |
Device and method for delivering therapeutic substances to the maxillary sinus of a patient
|
|
US20130109674A1
(en)
*
|
2009-12-18 |
2013-05-02 |
Achelios Therapeutics Llc |
Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
|
|
US20110184322A1
(en)
*
|
2010-01-22 |
2011-07-28 |
Slender Medical Ltd. |
Method and device for treatment of keloids and hypertrophic scars using focused ultrasound
|
|
US8507734B2
(en)
|
2010-03-03 |
2013-08-13 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising monoterpenes
|
|
US20130059914A1
(en)
|
2010-04-21 |
2013-03-07 |
Signature Therapeutics, Inc. |
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
|
|
WO2011133178A1
(en)
|
2010-04-21 |
2011-10-27 |
Pharmacofore, Inc |
Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
|
|
US20110262355A1
(en)
|
2010-04-21 |
2011-10-27 |
Jenkins Thomas E |
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
|
|
WO2011133179A1
(en)
*
|
2010-04-21 |
2011-10-27 |
Pharmacofore, Inc |
Compositions comprising enzyme-cleavable hydromorphone prodrug
|
|
US8617150B2
(en)
|
2010-05-14 |
2013-12-31 |
Liat Tsoref |
Reflectance-facilitated ultrasound treatment
|
|
US8956346B2
(en)
|
2010-05-14 |
2015-02-17 |
Rainbow Medical, Ltd. |
Reflectance-facilitated ultrasound treatment and monitoring
|
|
US9242122B2
(en)
|
2010-05-14 |
2016-01-26 |
Liat Tsoref |
Reflectance-facilitated ultrasound treatment and monitoring
|
|
CN102905720A
(zh)
|
2010-05-18 |
2013-01-30 |
日内瓦大学 |
催产素样分子的新用途及相关的方法
|
|
AU2011276170B2
(en)
*
|
2010-07-06 |
2016-03-10 |
Grunenthal Gmbh |
Novel gastro- retentive dosage forms comprising a GABA Analog and an opioid
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
EP3173080B1
(en)
|
2010-08-27 |
2019-12-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising derivatives of perillyl alcohol
|
|
GB201015371D0
(en)
*
|
2010-09-14 |
2010-10-27 |
Optinose As |
Nasal delivery
|
|
US8647661B1
(en)
*
|
2010-11-05 |
2014-02-11 |
Florida A&M University |
Surface modified multilayered nanostructures for dermal delivery
|
|
CN105616391B
(zh)
|
2010-12-17 |
2021-03-19 |
尼昂克技术公司 |
使用异紫苏醇的方法和装置
|
|
AU2012205733B2
(en)
|
2011-01-11 |
2015-10-08 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable oxycodone prodrug
|
|
US8497237B2
(en)
|
2011-01-11 |
2013-07-30 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable oxycodone prodrug
|
|
US20120183580A1
(en)
*
|
2011-01-13 |
2012-07-19 |
Theralpha |
Analgesic Composition for Transbuccal Administration
|
|
US12279989B2
(en)
|
2011-02-04 |
2025-04-22 |
Seed Health, Inc. |
Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
|
|
US12257272B2
(en)
|
2015-12-24 |
2025-03-25 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing depression in an individual
|
|
US10687975B2
(en)
*
|
2011-02-04 |
2020-06-23 |
Joseph E. Kovarik |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US11523934B2
(en)
|
2011-02-04 |
2022-12-13 |
Seed Health, Inc. |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US12533312B2
(en)
|
2011-02-04 |
2026-01-27 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
|
JP6148182B2
(ja)
|
2011-03-09 |
2017-06-14 |
シグネーチャー セラピューティクス, インク.Signature Therapeutics, Inc. |
複素環式リンカーを有する活性薬剤プロドラッグ
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
WO2012123819A1
(en)
*
|
2011-03-15 |
2012-09-20 |
Optinose As Et Al |
Nasal delivery
|
|
EP3607943B1
(en)
*
|
2011-04-05 |
2024-09-11 |
Grünenthal GmbH |
Tapentadol for use in treating pain associated with trigeminal neuralgia
|
|
ES2703282T3
(es)
|
2011-04-05 |
2019-03-07 |
Gruenenthal Gmbh |
Tapentadol para prevenir la cronificación del dolor
|
|
US20120277319A1
(en)
|
2011-04-29 |
2012-11-01 |
Gruenenthal Gmbh |
Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety
|
|
US8609088B2
(en)
|
2011-05-10 |
2013-12-17 |
Regents Of The University Of Minnesota |
Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
|
|
US8987199B2
(en)
|
2011-06-15 |
2015-03-24 |
Nerve Access, Inc. |
Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders
|
|
US9402877B2
(en)
|
2011-11-04 |
2016-08-02 |
Xion Pharmaceuticals Corporation |
Methods and compositions for oral administration of melanocortin receptor agonist compounds
|
|
US11213501B2
(en)
|
2011-12-27 |
2022-01-04 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US9962391B2
(en)
|
2011-12-27 |
2018-05-08 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US10813897B2
(en)
|
2011-12-27 |
2020-10-27 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US11213500B2
(en)
|
2011-12-27 |
2022-01-04 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US9468599B2
(en)
|
2011-12-27 |
2016-10-18 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
CA2856451A1
(en)
*
|
2012-01-05 |
2013-07-11 |
Beech Tree Labs, Inc. |
Method of treating pain by administration of nerve growth factor
|
|
US9707414B2
(en)
|
2012-02-14 |
2017-07-18 |
Rainbow Medical Ltd. |
Reflectance-facilitated ultrasound treatment and monitoring
|
|
US9308163B2
(en)
|
2012-02-15 |
2016-04-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of treating and preventing diseases and disorders of the central nervous system
|
|
US9789135B2
(en)
|
2012-07-20 |
2017-10-17 |
Taiga Biotechnologies, Inc. |
Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
|
|
ES2442242B1
(es)
*
|
2012-08-09 |
2014-11-25 |
Biotechnology Institute, I Mas D, S.L. |
Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
|
|
CN104902836B
(zh)
|
2012-11-05 |
2017-08-08 |
毕达哥拉斯医疗有限公司 |
受控组织消融
|
|
US9770593B2
(en)
|
2012-11-05 |
2017-09-26 |
Pythagoras Medical Ltd. |
Patient selection using a transluminally-applied electric current
|
|
WO2014085571A1
(en)
*
|
2012-11-28 |
2014-06-05 |
Nektar Therapeutics |
Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase i inhibitor
|
|
US9050330B2
(en)
*
|
2012-12-06 |
2015-06-09 |
Jose C. Ramon-de-Jesus |
Method, composition and kit for treating frequent headaches
|
|
US10639439B2
(en)
|
2013-01-30 |
2020-05-05 |
Midwest Pharmaceuticals, Llc |
Smokeless THC and administration method thereof
|
|
US20140294923A1
(en)
*
|
2013-02-20 |
2014-10-02 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of migraine headache
|
|
US9365825B2
(en)
|
2013-03-11 |
2016-06-14 |
Taiga Biotechnologies, Inc. |
Expansion of adult stem cells in vitro
|
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
|
CA2906737C
(en)
|
2013-03-15 |
2023-08-15 |
Amgen Inc. |
Human pac1 antibodies
|
|
CN115120746A
(zh)
|
2013-05-15 |
2022-09-30 |
明尼苏达大学董事会 |
腺相关病毒介导的基因向中枢神经系统转移
|
|
US20150086616A1
(en)
*
|
2013-09-20 |
2015-03-26 |
Steven Lehrer |
Method for the prevention and treatment of alzheimer's disease
|
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
|
US12329783B2
(en)
|
2013-12-20 |
2025-06-17 |
Seed Health, Inc. |
Method and system to improve the health of a person's skin microbiome
|
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
|
US12246043B2
(en)
|
2013-12-20 |
2025-03-11 |
Seed Health, Inc. |
Topical application to treat acne vulgaris
|
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
|
US10556945B2
(en)
|
2014-03-21 |
2020-02-11 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
|
AU2015230933B2
(en)
|
2014-03-21 |
2020-08-13 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
|
CN106659531A
(zh)
|
2014-05-07 |
2017-05-10 |
毕达哥拉斯医疗有限公司 |
受控组织消融技术
|
|
AU2015277272A1
(en)
*
|
2014-06-16 |
2017-01-12 |
Loewi LLC |
Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
|
|
WO2016044224A1
(en)
|
2014-09-15 |
2016-03-24 |
Amgen Inc. |
Bi-specific anti-cgrp receptor/pac1 receptor antigen binding proteins and uses thereof
|
|
PL3200764T3
(pl)
*
|
2014-10-01 |
2020-12-28 |
Oxytone Bioscience B.V. |
Rozpadająca się w jamie ustnej stała farmaceutyczna jednostka dawkowania zawierająca substancję kontrolującą poród
|
|
RU2701199C2
(ru)
|
2014-10-01 |
2019-09-25 |
Окситон Байосайенс Б.В. |
Перорально распадающаяся твердая фармацевтическая единица дозирования, содержащая контролирующее родовую деятельность вещество
|
|
EP3848028B9
(en)
|
2014-10-20 |
2024-10-16 |
Oyster Point Pharma, Inc. |
Methods of treating ocular conditions
|
|
WO2016065075A1
(en)
|
2014-10-21 |
2016-04-28 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics
|
|
US10388407B2
(en)
|
2014-10-21 |
2019-08-20 |
uBiome, Inc. |
Method and system for characterizing a headache-related condition
|
|
US10940277B2
(en)
|
2014-11-19 |
2021-03-09 |
Optinose As |
Intranasal administration
|
|
WO2016089893A1
(en)
|
2014-12-01 |
2016-06-09 |
Achelios Therapeutics Inc. |
Methods and compositions for treating migraine and conditions associated with pain
|
|
SG11201705591PA
(en)
*
|
2015-01-07 |
2017-08-30 |
Trigemina Inc |
Magnesium-containing oxytocin formulations and methods of use
|
|
US9744209B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9744239B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9925233B2
(en)
|
2015-01-30 |
2018-03-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9937223B2
(en)
|
2015-01-30 |
2018-04-10 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9750785B2
(en)
|
2015-01-30 |
2017-09-05 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9687526B2
(en)
|
2015-01-30 |
2017-06-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
KR20170131405A
(ko)
|
2015-02-12 |
2017-11-29 |
네온씨 테크놀로지스, 아이엔씨. |
페릴릴 알코올 유도체를 포함하는 의약 조성물
|
|
WO2016140063A1
(ja)
*
|
2015-03-04 |
2016-09-09 |
栄研化学株式会社 |
オキシトシンの高感度測定法
|
|
US10899834B2
(en)
|
2015-04-16 |
2021-01-26 |
H. Lundbeck A/S |
Anti-PACAP antibodies
|
|
US10383685B2
(en)
|
2015-05-07 |
2019-08-20 |
Pythagoras Medical Ltd. |
Techniques for use with nerve tissue
|
|
US11207461B2
(en)
|
2015-07-30 |
2021-12-28 |
Anoop U. R |
Drug delivery system and method for controlled and continuous delivery of drugs into the brain by bypassing the blood brain barrier
|
|
US11213480B1
(en)
|
2015-08-06 |
2022-01-04 |
Hikma Pharmaceuticals International Limited |
Phenylephrine hydrochloride ready-to-use solution
|
|
US10335406B2
(en)
|
2015-10-01 |
2019-07-02 |
Elysium Therapeutics, Inc. |
Opioid compositions resistant to overdose and abuse
|
|
AU2016332071B2
(en)
|
2015-10-01 |
2019-04-18 |
Elysium Therapeutics, Inc. |
Polysubunit opioid prodrugs resistant to overdose and abuse
|
|
US10822408B2
(en)
|
2015-12-15 |
2020-11-03 |
Amgen Inc. |
PACAP antibodies and uses thereof
|
|
JP7093559B2
(ja)
|
2016-04-12 |
2022-06-30 |
トライジェミナ， インコーポレイテッド |
マグネシウム含有オキシトシン製剤および使用の方法
|
|
KR102444717B1
(ko)
|
2016-04-15 |
2022-09-16 |
하. 룬드벡 아크티에셀스카브 |
인간화 항-pacap 항체 및 그의 용도
|
|
SG10201912761UA
(en)
|
2016-04-15 |
2020-02-27 |
The Trustees Of The Univ Of Pennsyvania |
Gene therapy for treating mucopolysaccharidosis type ii
|
|
US11678932B2
(en)
|
2016-05-18 |
2023-06-20 |
Symap Medical (Suzhou) Limited |
Electrode catheter with incremental advancement
|
|
CN109952314A
(zh)
|
2016-09-23 |
2019-06-28 |
泰瓦制药国际有限公司 |
治疗难治性偏头痛
|
|
EP3687375A4
(en)
*
|
2016-11-21 |
2022-01-19 |
Psomagen, Inc. |
METHOD AND SYSTEM FOR CHARACTERIZING A HEADACHE RELATED CONDITION
|
|
DK3547836T3
(da)
|
2016-11-30 |
2024-11-18 |
Univ Southern California |
Perillylalkohol-3 brompyruvat-konjugat og fremgangsmåder til behandling af cancer
|
|
EP3548425B1
(en)
|
2016-12-02 |
2023-03-29 |
Taiga Biotechnologies, Inc. |
Nanoparticle formulations
|
|
US10456419B2
(en)
|
2017-02-27 |
2019-10-29 |
Payman Sadeghi |
Method for treating migraine headaches
|
|
US10932711B2
(en)
|
2017-02-27 |
2021-03-02 |
Payman Sadeghi |
Method and system for neurohydrodissection
|
|
EP3595663A4
(en)
|
2017-03-17 |
2021-01-13 |
Elysium Therapeutics, Inc. |
MULTIPLE SUBUNITY OPIOID PRODRUGS WITH RESISTANCE TO OVERDOSE AND ABUSE
|
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
|
KR102883778B1
(ko)
|
2017-09-22 |
2025-11-12 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
Ii형 점액다당류증의 치료를 위한 유전자 요법
|
|
SG11202006610YA
(en)
|
2018-01-12 |
2020-08-28 |
Amgen Inc |
Pac1 antibodies and uses thereof
|
|
DK3749291T3
(da)
|
2018-02-08 |
2024-04-08 |
Univ Southern California |
Fremgangsmåder til permeabilisering af blod-hjerne-barrieren
|
|
US20210346385A1
(en)
*
|
2018-09-21 |
2021-11-11 |
MSB Holdings, Inc |
Taste-masked dosage forms
|
|
US11135379B2
(en)
|
2019-02-15 |
2021-10-05 |
Bn Intellectual Properties, Inc. |
Method of delivering pharmaceutical products
|
|
BR112021018086A2
(pt)
|
2019-03-14 |
2021-11-23 |
Univ Arizona |
Método de tratamento e/ou prevenção de asma, exacerbações de asma, asma alérgica e/ou condições associadas com microbiota relacionadas a distúrbios respiratórios
|
|
CN113874033A
(zh)
|
2019-04-08 |
2021-12-31 |
泰加生物工艺学公司 |
用于冷冻保存免疫细胞的组合物和方法
|
|
EP3969041A4
(en)
|
2019-05-14 |
2023-05-10 |
Taiga Biotechnologies, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF T-CELL DEPLETION
|
|
WO2021016190A1
(en)
*
|
2019-07-19 |
2021-01-28 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Compositions and methods for modulating drug-use disorders
|
|
US11364225B2
(en)
*
|
2019-08-21 |
2022-06-21 |
Bn Intellectual Properties, Inc. |
Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same
|
|
AU2020335930B2
(en)
*
|
2019-08-29 |
2025-06-05 |
Maskbegone Llc |
Oxytocin compositions for treatment of tinnitus
|
|
WO2021072055A1
(en)
*
|
2019-10-11 |
2021-04-15 |
Board Of Regents, The University Of Texas System |
Compositions and methods for preventing, reducing and reversing opioid-induced respiratory depression
|
|
NL2030835B1
(en)
|
2020-01-24 |
2022-12-29 |
Aim Immunotech Inc |
Methods, compositions, and vaccinces for treating a virus infection
|
|
EP4192436A4
(en)
*
|
2020-08-10 |
2024-10-02 |
Ziropa, Inc. |
COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION
|
|
IL305493A
(en)
|
2021-03-09 |
2023-10-01 |
Ensysce Biosciences Inc |
Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof
|
|
CA3230025A1
(en)
|
2021-09-29 |
2023-04-06 |
Lynn Kirkpatrick |
Enzyme-cleavable methadone prodrugs and methods of use thereof
|
|
EP4469074A1
(en)
*
|
2022-01-27 |
2024-12-04 |
Belnap Pharmaceuticals, LLC |
Methods of treatment using oxytocin
|
|
AU2023375349A1
(en)
*
|
2022-11-07 |
2025-05-22 |
AEON Biopharma, Inc. |
Compositions for use in treating headache disorders
|
|
WO2025064708A1
(en)
*
|
2023-09-22 |
2025-03-27 |
The George Washington University |
Compositions comprising oxytocin and methods of treating opioid overdose
|
|
WO2025199179A2
(en)
|
2024-03-18 |
2025-09-25 |
Tonix Pharmaceuticals Holding Corp. |
Oxytocin peptide analogs
|